Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia

Autor: El-Jawahri, Areej, Li, Shuli, Ballen, Karen K., Cutler, Corey, Dey, Bimalangshu R., Driscoll, Jessica, Hunnewell, Chrisa, Ho, Vincent T., McAfee, Steven L., Poliquin, Cathleen, Saylor, Meredith, Soiffer, Robert J., Spitzer, Thomas R., Alyea, Edwin, Chen, Yi-Bin
Zdroj: In Biology of Blood and Marrow Transplantation January 2016 22(1):80-85
Databáze: ScienceDirect